Scientists of the Samara National Research University together with specialists of the Research Institute of Eye Diseases of the Samara Regional Ophthalmologic Hospital named after TI Eroshevsky have developed a new technology for the prevention of postoperative complications in ophthalmology. This is reported by TASS with reference to the press service of the Samara University.
“Scientists have developed a new drug composition and a new method of applying an anti-inflammatory drug to the operated eye.This development will reduce the number of postoperative complications and accelerate the recovery of patients after the operation before the eyes,” the report said.
As noted in the press service, surgery today is one of the most common methods of restoring vision. Every year around 650,000 operations are performed in the world, of which over 30,000 are performed in Russia. Moreover, the postoperative period includes the treatment of the operated eye with certain drugs.
According to the developers, the problem is that existing technologies do not allow to calculate the individual dose of the drug solution absolutely accurately, and apply it in a strictly defined place, without affecting surrounding tissues. Therefore, now postoperative treatment is often performed “with a margin”, which can lead to drug overdose, the emergence of postoperative complications and an increase in the rehabilitation period.
Samara scientists suggested using microcrystalline cellulose as a carrier of the medicine.
“The use of this substance will achieve … dosed and local drug delivery to the eye area, which avoids the toxic effect of the drug on neighboring healthy tissues and the body as a whole,” the press service explained.
It is reported that Samara’s development of efficiency and safety is not inferior to the world’s analogues, but it is much more accessible to patients. The cost of one pack of imported medicine for postoperative eye treatment in Russia is on average more than $ 350. Domestic drug using microcellulose will cost 6-7 times cheaper.
Now the Samara Regional Ophthalmologic Hospital is conducting clinical development trials.
Continue at: https://scientificrussia.ru/news/uchenye-iz-samary-sozdali-novuyu-tehnologiyu-profilaktiki-posleoperatsionnyh-oslozhnenij-v-oftalmologii
The text above is owned by the site bellow referred.
Here is only a small part of the article, for more please follow the link